Bharathi Avula , Kumar Katragunta , Kiran Kumar Tatapudi , Yan-Hong Wang , Zulfiqar Ali , Amar G. Chittiboyina , Ikhlas A. Khan
{"title":"Phytochemical analysis of phenolics and diterpene lactones in Andrographis paniculata plant samples and dietary supplements","authors":"Bharathi Avula , Kumar Katragunta , Kiran Kumar Tatapudi , Yan-Hong Wang , Zulfiqar Ali , Amar G. Chittiboyina , Ikhlas A. Khan","doi":"10.1016/j.jpba.2025.116866","DOIUrl":null,"url":null,"abstract":"<div><div><em>Andrographis paniculata,</em> a popular immune-boosting supplement, faces quality concerns due to potential adulteration and reliance on single-marker quality assurance. To address these, a comprehensive UHPLC-PDA and LC-QToF-MS method was developed and validated to quantify and identify three classes of compounds: phenolic acids, diterpenoid lactones (including their glycosides), and flavonoid glycosides. The method achieved LOD of 10<img>300 ng/mL and LOQ of 25<img>1000 ng/mL for fourteen reference standards. Analysis of plant samples revealed total phenolic acids (<strong>1–4</strong>; 0.3–13 mg/g), flavonoid glycosides (<strong>6</strong>, <strong>10</strong>, and <strong>11</strong>; 0.2–2 mg/g), diterpene lactones (<strong>7</strong>, <strong>13</strong>, and <strong>14</strong>; 1.4–31 mg/g), and diterpene lactone glycosides (<strong>5</strong>, <strong>8</strong>, <strong>9</strong>, and <strong>12</strong>; 0.6–17 mg/g). Furthermore, over 100 phytochemicals were tentatively identified based on characteristic mass spectral features in <em>A. paniculata</em>. Applying this comprehensive phytochemical profile to various supplement products revealed that over 25 % of commercial <em>A. paniculata</em> products failed to meet pharmacopeia standards. Detailed analysis demonstrated significant variations in the plant-part-specific distribution of diterpene lactone and its glycosides, as well as flavonoid glycosides. Some products exhibited elevated mean values for these three analyte groups, while others showed significantly lower values contributing to the observed failures. Moreover, the analytical data revealed a significant discrepancy in andrographolide (<strong>7</strong>) content, a standard quality assurance marker, between plant materials (0.4–23 mg/g) and dietary supplements (0–278 mg/serving size). Specifically, a 13 % andrographolide decrease and a corresponding increase in 14-deoxy-11,12-didehydroandrographolide (<strong>14</strong>) in <em>A. paniculata</em> capsules suggest processing-induced dehydration, necessitating optimized production to maintain biologically active andrographolide content. These findings underscore the necessity for rigorous quality control and comprehensive analytical methods to ensure the quality assurance of <em>A. paniculata</em> supplements.</div></div>","PeriodicalId":16685,"journal":{"name":"Journal of pharmaceutical and biomedical analysis","volume":"262 ","pages":"Article 116866"},"PeriodicalIF":3.1000,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmaceutical and biomedical analysis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0731708525002079","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Andrographis paniculata, a popular immune-boosting supplement, faces quality concerns due to potential adulteration and reliance on single-marker quality assurance. To address these, a comprehensive UHPLC-PDA and LC-QToF-MS method was developed and validated to quantify and identify three classes of compounds: phenolic acids, diterpenoid lactones (including their glycosides), and flavonoid glycosides. The method achieved LOD of 10300 ng/mL and LOQ of 251000 ng/mL for fourteen reference standards. Analysis of plant samples revealed total phenolic acids (1–4; 0.3–13 mg/g), flavonoid glycosides (6, 10, and 11; 0.2–2 mg/g), diterpene lactones (7, 13, and 14; 1.4–31 mg/g), and diterpene lactone glycosides (5, 8, 9, and 12; 0.6–17 mg/g). Furthermore, over 100 phytochemicals were tentatively identified based on characteristic mass spectral features in A. paniculata. Applying this comprehensive phytochemical profile to various supplement products revealed that over 25 % of commercial A. paniculata products failed to meet pharmacopeia standards. Detailed analysis demonstrated significant variations in the plant-part-specific distribution of diterpene lactone and its glycosides, as well as flavonoid glycosides. Some products exhibited elevated mean values for these three analyte groups, while others showed significantly lower values contributing to the observed failures. Moreover, the analytical data revealed a significant discrepancy in andrographolide (7) content, a standard quality assurance marker, between plant materials (0.4–23 mg/g) and dietary supplements (0–278 mg/serving size). Specifically, a 13 % andrographolide decrease and a corresponding increase in 14-deoxy-11,12-didehydroandrographolide (14) in A. paniculata capsules suggest processing-induced dehydration, necessitating optimized production to maintain biologically active andrographolide content. These findings underscore the necessity for rigorous quality control and comprehensive analytical methods to ensure the quality assurance of A. paniculata supplements.
期刊介绍:
This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focusing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome.
Studies from areas of well established and poorly selective methods, such as UV-VIS spectrophotometry (including derivative and multi-wavelength measurements), basic electroanalytical (potentiometric, polarographic and voltammetric) methods, fluorimetry, flow-injection analysis, etc. are accepted for publication in exceptional cases only, if a unique and substantial advantage over presently known systems is demonstrated. The same applies to the assay of simple drug formulations by any kind of methods and the determination of drugs in biological samples based merely on spiked samples. Drug purity/stability studies should contain information on the structure elucidation of the impurities/degradants.